Eli Lilly's one-two punch could knock Novo Nordisk out of the obesity drug fight

The U.S. Food & Drug Administration just approved Eli Lilly's GLP-1 pill orforglipron.
AOL

GLP-1 wars: Wegovy maker challenges knock-off weight loss drug companies

Many Americans seeking popular weight-loss drugs like Wegovy and Zepbound turn to telehealth companies like Hims & Hers for cheaper, compounded alternatives. Those compounded drugs were only supposed ...
EurekAlert!

This new, one-two punch could knock out drug-resistant TB

Researchers found that pairing the antibiotic rifampicin with a second compound turned multidrug resistance into a weakness—providing proof of concept for using basic science to design life-saving ...
AOL

Hims & Hers removes a knock-off weight loss drug days after introducing it

Hims & Hers introduced a weight loss pill on Thursday.SOPA Images/SOPA Images/LightRocket via Getty Images Hims & Hers unveiled a once-a-day weight-loss pill this week, calling it an alternative for ...